Drugs / SAAVI DNA-C2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00574600 | Nov 2008 → Oct 2010 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAAVI DNA-C2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00574600 ↗ |
| Modality | Vaccine | “DNA vaccine” NCT00574600 ↗ |
| Route | Intramuscular | “1 ml intramuscularly” NCT00574600 ↗ |